These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28006819)

  • 21. Development and evaluation of the virtual pathology slide: a new tool in telepathology.
    Costello SS; Johnston DJ; Dervan PA; O'Shea DG
    J Med Internet Res; 2003; 5(2):e11. PubMed ID: 12857667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of whole slide imaging in the primary diagnosis of gynaecological pathology in a University Hospital.
    Ordi J; Castillo P; Saco A; Del Pino M; Ordi O; Rodríguez-Carunchio L; Ramírez J
    J Clin Pathol; 2015 Jan; 68(1):33-9. PubMed ID: 25355520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New developments in digital pathology: from telepathology to virtual pathology laboratory.
    Kayser K; Kayser G; Radziszowski D; Oehmann A
    Stud Health Technol Inform; 2004; 105():61-9. PubMed ID: 15718595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial.
    Verleye L; Ottevanger PB; Kristensen GB; Ehlen T; Johnson N; van der Burg ME; Reed NS; Verheijen RH; Gaarenstroom KN; Mosgaard B; Seoane JM; van der Velden J; Lotocki R; van der Graaf W; Penninckx B; Coens C; Stuart G; Vergote I
    Eur J Cancer; 2011 Jan; 47(1):57-64. PubMed ID: 20850296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality control in ovarian cancer surgery.
    Hacker NF
    Ann Oncol; 2011 Dec; 22 Suppl 8():viii19-viii22. PubMed ID: 22180394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The postoperative therapy of epithelial ovarian carcinoma. Has systemic cytostasis replaced percutaneous radiation?].
    Souchon R; Cwiekala M
    Strahlenther Onkol; 1995 Nov; 171(11):630-40. PubMed ID: 7502226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists?
    Tyler CW; Lee NC; Robboy SJ; Kurman RJ; Paris AL; Wingo PA; Williamson GD
    Am J Obstet Gynecol; 1991 Jan; 164(1 Pt 1):65-70. PubMed ID: 1986629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early-stage epithelial ovarian cancer: an overview.
    Chiari S; Rota S; Zanetta G; Vecchione F; Caspani G
    Forum (Genova); 2000; 10(4):298-307. PubMed ID: 11535981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adjuvant chemotherapy in patients operated on for early ovarian carcinoma].
    Trimbos JB; van der Burg ME
    Ned Tijdschr Geneeskd; 2004 May; 148(18):874-8. PubMed ID: 15152388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial ovarian tumors of borderline malignancy.
    Chao TM; Yen MS; Chao KC; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers.
    Nagtegaal ID; Kranenbarg EK; Hermans J; van de Velde CJ; van Krieken JH
    J Clin Oncol; 2000 Apr; 18(8):1771-9. PubMed ID: 10764439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours.
    Querleu D; Papageorgiou T; Lambaudie E; Sonoda Y; Narducci F; LeBlanc E
    BJOG; 2003 Feb; 110(2):201-4. PubMed ID: 12618166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).
    Wimberger P; Wehling M; Lehmann N; Kimmig R; Schmalfeldt B; Burges A; Harter P; Pfisterer J; du Bois A
    Ann Surg Oncol; 2010 Jun; 17(6):1642-8. PubMed ID: 20165986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement for expert histopathological assessment of ovarian cancer and borderline tumors.
    Sengupta PS; Shanks JH; Buckley CH; Ryder WD; Davies J; Reynolds K; Slade RJ; Kitchener HC; Jayson GC
    Br J Cancer; 2000 Feb; 82(4):760-2. PubMed ID: 10732741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assurance of pathology in clinical trials. The National Surgical Adjuvant Breast and Bowel Project experience.
    Fisher ER; Costantino J
    Cancer; 1994 Nov; 74(9 Suppl):2638-41. PubMed ID: 7954278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What can the pathologist offer for optimal treatment choice?
    Viale G; Mastropasqua MG
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii27-9. PubMed ID: 20943626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Process and outcome of care for patients with ovarian cancer.
    Liberati A; Mangioni C; Bratina L; Carinelli G; Marsoni S; Parazzini F; Regallo M; Talamini R; Tognoni G
    Br Med J (Clin Res Ed); 1985 Oct; 291(6501):1007-12. PubMed ID: 3931767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Ask The Pathologist": An Internet Forum Facilitating Communication Between Cancer Registrars and Pathologists.
    Strickland-Marmol LB; Muro-Cacho CA; Washington K; Foulis PR
    Arch Pathol Lab Med; 2018 Oct; 142(10):1275-1283. PubMed ID: 29846103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.